Skip to Content

Tbo-filgrastim Pregnancy and Breastfeeding Warnings

Tbo-filgrastim is also known as: Granix

Tbo-filgrastim Pregnancy Warnings

Use of tbo-filgrastim is not recommended unless the benefit outweighs the risk to the developing fetus. FDA pregnancy category: C

Animal studies have revealed evidence of maternal toxicity, embryolethality, and fetotoxicity. There are no controlled data in human pregnancy. Filgrastim is only recommended for use during pregnancy only if the potential benefit justifies the potential risk to the fetus. FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Tbo-filgrastim Breastfeeding Warnings

Other recombinant granulocyte colony stimulating factor (G-CSF) products are poorly secreted in breast milk and G-CSF is not orally absorbed by neonates.

Caution is recommended. Excreted into human milk: Unknown Excreted into animal milk: Data not available The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Granix (tbo-filgrastim)." Teva Pharmaceuticals USA, North Wales, PA.

References for breastfeeding information

  1. "Product Information. Granix (tbo-filgrastim)." Teva Pharmaceuticals USA, North Wales, PA.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.